Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
53.5 USD | +6.19% | +17.92% | +398.60% |
May. 30 | Scotiabank Starts Janux Therapeutics With Sector Perform Rating | MT |
May. 30 | Certain Pre Funded Warrants of Janux Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 30-MAY-2024. | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+398.60% | 2.77B | |
+43.36% | 54.63B | |
-5.31% | 39.92B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B | |
-11.83% | 10.74B |
- Stock Market
- Equities
- JANX Stock
- News Janux Therapeutics, Inc.
- Janux Therapeutics Prices $296.5 Million Offering of Common Stock, Pre-Funded Warrants